René Gantier
Senior Director of R&D for Advanced Bioprocess Applications, Repligen Corporation
René Gantier has over 20 years of experience developing production and purification processes for biotherapies. In his current role, he leads the development of advanced bioprocess applications and technologies with a focus on next-generation cell and gene therapy manufacturing processes. Before joining Repligen, he led the Biotech Process R&D team at Pall Life Sciences, where he developed end-to-end upstream-downstream continuous bioprocessing solutions for mAbs and cell/gene therapies. René holds an MSc in Cell Biology from the University of Nantes (France) and a PhD in Biochemistry from the University of Rouen (France).